Research Article

Are Basal-Like and Non-Basal-Like Triple-Negative Breast Cancers Really Different?

Table 3

Comparison between basal-like and non-basal-like subtypes.

Characteristic (N)Basal-like N (%)Non-basal-like N (%)Chi-square value

Menstrual history (200)
 Premenopausal44 (43.6)37 (37.4)0.9220.631
 Perimenopausal7 (6.9)9 (9.1)
 Postmenopausal50 (49.5)53 (53.5)
Age at first childbirth (years) (99)
 15–205 (11.1)9 (16.7)6.1890.185
 21–2527 (60)24 (44.4)
 26–3010 (22.2)12 (22.2)
 31–351 (2.2)0 (0)
 Not yet2 (4.4)9 (16.7)
Parity (150)
 112 (16.2)7 (9.2)8.2850.141
 225 (33.8)32 (42.1)
 321 (28.4)22 (28.9)
 4 or more14 (18.9)8 (10.5)
 Not yet2 (2.7)7 (9.2)
Family history of cancer (149)
 Yes18 (24)16 (21.6)0.1200.729
 No57 (76)58 (78.4)
Stage (200)
 I3 (3)8 (8.1)3.9060.272
 II69 (68.3)67 (67.7)
 III22 (21.8)21 (21.2)
 IV7 (6.9)3 (3)
Grade (200)
 II11 (10.9)16 (16.2)0.3060.189
 III90 (89.1)83 (83.8)
Lymph node status (189)
 Positive43 (46.7)43 (44.3)0.1110.740
 Negative49 (53.3)54 (55.7)
Extracapsular extension (86)
 Present26 (60.5)32 (74.4)1.9060.167
 Absent17 (39.5)11 (25.6)
Lymphovascular invasion (194)
 Present35 (34.7)46 (46.5)7.9080.019
 Absent60 (59.4)53 (53.5)
Recurrence type (32)
 Local1 (6.3)1 (6.3)1.0340.596
 Locoregional0 (0)1 (6.3)
 Distant15 (93.8)14 (87.5)
Vital status (200)
 Alive78 (77.2)83 (83.8)1.3920.238
 Death23 (22.8)16 (16.2)
Cause of death (39)
 Disease-related21 (91.3)12 (75)1.927
 Non-disease-related2 (8.7)4 (25)0.165

.